Here’s what Chromadex CEO Rob Fried said on a recent podcast about clinical studies looking at Nicotinamide Riboside “NR” (FAQs) (Reviews):
Month: April 2021
Over the last year, we’ve heard some incredible stories from readers impacted by taking NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). While all of these stories are beyond extraordinary (especially Dave & Fertility, Mark & Epilepsy, Gary & Psoriasis), we’re seeing some remarkable consistency. Many people are reporting among other things: faster recovery, better sleep, improved skin, and the return of natural hair color. Today’s submission from Kirk Carter goes a step further (please consider sharing your own NAD+ supplement experience below):
At RaisingNAD, we often highlight Chromadex CEO Rob Fried’s many podcast appearances for a very simple reason. While he never reveals any information that isn’t already publicly available, he does however often explain the merits of supplementing with Nicotinamide Riboside “NR” (FAQs) (Reviews) in new, accessible, and more persuasive ways. Last week, he joined the Insider Opportunities podcast to discuss Nicotinamide Riboside (NR):
Last week, we heard from Gary Varvaro who believes Nicotinamide Riboside “NR” (FAQs) (Reviews) helped cure his Psoriasis. Now comes a story from Donna about a friend suffering from Alopecia (see below). These anecdotes appear to add more credibility to the belief that NR can play a role in impacting those suffering from autoimmune diseases (please consider sharing your own NAD+ supplement experience below).
Until now, conventional wisdom has been that your NAD levels start declining in your 20s and plunge between ages 40 and 60. But in the latest episode of Linda Cooper’s “The New 100 Longevity Campaign”, NAD expert Dr. Charles Brenner appears to have evolved his thinking. As a result, we too might have to evolve our own thinking about when to begin supplementing with NAD boosters like Nicotinamide Riboside “NR” (FAQs) (Reviews).
Last year, the NIH launched a pilot study “to test if the dietary supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) can improve immune system function in the blood and skin of people with mild to moderate psoriasis”. According to the study’s principal investigator Dr. Michael Sack, “as the disease (psoriasis) gets more advanced, it can affect the joints, so you can get arthritis. The chronic inflammation can have systemic effects. We’re trying to see in the mild to moderate disease range whether we can prevent (these effects on the entire body)”. The NIH study is expected to be completed on September 30, 2023. In the meantime, we’re fortunate to have the following remarkable submission received yesterday (please consider sharing your own NAD+ supplement experience below):
For most of us, NAD is a foreign concept. But, according to top scientists, it’s critical to human health. Why does NAD remain under the radar? Because it’s not a simple concept. It’s not easily accessible. So, when we at RaisingNAD find an interview or video which explains NAD in plain simple English we jump at the opportunity to share it. The following is an example from last week: